TG-02 (Targovax)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameTG-02 (Targovax)
Drug Alias NameTG-02-Targovax
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCytotoxic T lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsHigh-Grade Glioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesTargovax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLee'S Pharmaceutical Ltd
Active IndicationsN/A
Inactive IndicationsHigh-Grade Glioma

Other Information

ATC CodeN/A
Related LinksN/A